Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1842 2
1935 1
1941 1
1945 2
1946 5
1947 2
1948 6
1949 4
1950 7
1951 9
1952 14
1953 12
1954 13
1955 7
1956 5
1957 7
1958 7
1959 3
1960 3
1961 3
1962 1
1963 1
1964 2
1966 1
1969 1
1970 2
1972 1
1973 1
1974 3
1975 1
1976 2
1977 1
1978 3
1979 6
1982 4
1983 1
1984 2
1985 1
1986 2
1988 4
1989 3
1990 4
1992 1
1993 1
1994 4
1995 2
1996 4
1997 4
1998 8
1999 9
2000 7
2001 3
2002 3
2003 2
2004 4
2005 5
2006 8
2007 6
2008 4
2009 3
2010 9
2011 6
2012 5
2013 5
2014 5
2015 6
2016 5
2017 7
2018 5
2019 9
2020 7
2021 10
2022 8
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice ASC, Bouhassira D, Bennett DL, Selvarajah D; OPTION-DM trial group. Tesfaye S, et al. Among authors: glover r. Lancet. 2022 Aug 27;400(10353):680-690. doi: 10.1016/S0140-6736(22)01472-6. Epub 2022 Aug 22. Lancet. 2022. PMID: 36007534 Free PMC article. Clinical Trial.
Comparison of RPE (Rating of Perceived Exertion) Scales for Session RPE.
Arney BE, Glover R, Fusco A, Cortis C, de Koning JJ, van Erp T, Jaime S, Mikat RP, Porcari JP, Foster C. Arney BE, et al. Among authors: glover r. Int J Sports Physiol Perform. 2019 Jul 1;14(7):994-996. doi: 10.1123/ijspp.2018-0637. Int J Sports Physiol Perform. 2019. PMID: 30569764
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Julious SA, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude E, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Bouhassira D, Bennett DL, Selvarajah D. Tesfaye S, et al. Among authors: glover r. Health Technol Assess. 2022 Oct;26(39):1-100. doi: 10.3310/RXUO6757. Health Technol Assess. 2022. PMID: 36259684 Free PMC article. Clinical Trial.
Antimicrobial resistance at the G7.
Glover RE, Knight GM, Chandler CIR. Glover RE, et al. BMJ. 2021 Jun 3;373:n1417. doi: 10.1136/bmj.n1417. BMJ. 2021. PMID: 34083377 No abstract available.
Subscription model for antibiotic development.
Glover RE, Manton J, Willcocks S, Stabler RA. Glover RE, et al. BMJ. 2019 Sep 6;366:l5364. doi: 10.1136/bmj.l5364. BMJ. 2019. PMID: 31492658 No abstract available.
Sustainability in Laboratory Medicine.
Glover RT, Connelly J, Gammie A, Kilcoyne J, Ozben T, Santos A, Wiencek JR. Glover RT, et al. Clin Chem. 2023 Nov 2;69(11):1212-1219. doi: 10.1093/clinchem/hvad156. Clin Chem. 2023. PMID: 37795568 No abstract available.
Carrier-Envelope Phase-Dependent Strong-Field Excitation.
Chetty D, Glover RD, Tong XM, deHarak BA, Xu H, Haram N, Bartschat K, Palmer AJ, Luiten AN, Light PS, Litvinyuk IV, Sang RT. Chetty D, et al. Among authors: glover rd. Phys Rev Lett. 2022 Apr 29;128(17):173201. doi: 10.1103/PhysRevLett.128.173201. Phys Rev Lett. 2022. PMID: 35570453
332 results